Pharmacology Clofibrate, a lipid lowering agent inhibits both cholesterol and triglyceride synthesis by: A Inhibiting HMG CoA reductase B Binding to bile acids and preventing its reabsorption C Inhibiting VLDL production D Activating lipoprotein lipase, resulting in VLDL degradation 💡 Explanation Clofibrate, a lipid lowering agent inhibits both cholesterol and triglyceride synthesis by: ✓ Correct Answer: D. Activating lipoprotein lipase, resulting in VLDL degradation